C
Clearwater Analytics
Acquirer counsel
Kirkland & Ellis
Constantine N. Skarvelis, P.C.Partner
Marshall P. Shaffer, P.C.Partner
10 lawyers involved
Rainmaker
Loading page...
Kirkland & Ellis advises Clearwater Analytics on $1.5 billion acquisition of Enfusion, Inc.
Deal Overview
- Value
- $1.5bn
- Deal type
- M&A
- Structure
- Data in progress
- Status
- Data in progress
Advisors
ACQUIRER
Kirkland & Ellis Overview
- Clearwater Analytics is a NYSE-listed provider of SaaS-based investment management, accounting, reporting and analytics solutions, buying Enfusion, a SaaS provider to the investment management and hedge fund industry.
- The deal is priced at US$11.25 per share in an approximately equal mix of cash and stock, and Clearwater will also pay US$30 million to terminate Enfusion's tax receivable agreement.
- The transaction values Enfusion at about US$1.5 billion and was announced on January 13, 2025, with closing targeted for Q2 2025 subject to Enfusion shareholder approval, required regulatory approvals and customary conditions.
E
Enfusion, Inc.
Seller counsel
Dechert
Mark E. ThierfelderPartner
Eric S. SiegelPartner
Andrew J. LevanderPartner
Rick S. HorvathPartner
5 lawyers involved
Dechert Overview
- Enfusion is described in the deal announcement as a leader in SaaS solutions for the investment management and hedge fund industry.
- The transaction values Enfusion at US$1.5 billion under a definitive agreement for Clearwater Analytics to acquire the company.
- Closing is targeted for Q2 2025, subject to Enfusion shareholder approval, regulatory clearances and customary conditions; Clearwater said the acquisition advances its plan to build a cloud-native end-to-end investment management platform.